The justices are considering whether to roll back access to mifepristone, whose demand has swelled since the high court eliminated the constitutional right to an abortion.
Companies from Motorola Solutions to Intuit are leaning on their finance teams to weigh the possible benefits against the costs—and keep those costs in check.